15.4.2021 19:29:28 CEST | Aqua Bio Technology ASA | Mandatory notification of
trade primary insiders

Aqua Bio Technology ASA: Notifiable transaction in connection with Private
Placement

Reference is made to the stock exchange notice from Aqua Bio Technology ASA (the
"Company") on 15 April 2021 regarding completion of a private placement raising
gross proceeds of approximately NOK 15 million through issuance 1,303,707 new
shares (the "Private Placement").

In order to arrange settlement for certain of the new shares to be delivered in
the Private Placement, a share lending arrangement has been agreed with
Kjeveortoped Espen Dahl AS, a close associate of Board member Kristin Aase.
Pursuant to this arrangement, Kjeveortoped Espen Dahl AS has agreed to lend out
605,017 shares in the Company. Please see the attached form for further
information.

* * *

For further information, please contact Edvard Cock, Chairman, telephone +47 415
05 004.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skin care products has been, and will continue to be, an
important part of the Company's strategy going forward. Aqua Bio Technology is
listed on the Euronext Expand market of the Oslo Stock Exchange.

This information is such that Aqua Bio Technology ASA is required to disclose in
accordance with the EU Market Abuse Regulation, and is subject to the disclosure
requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
The stock exchange announcement was published by Håvard Lindstrøm, Head of
Business Development, on 15 April 2021, at 19:30 CEST.

 

 

DISCLAIMER

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

 * Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no 

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/458/585/Download%20announcement%2
0as%20PDF.pdf

Notification and public disclosure of transactions by Primary Insiders and their
Close Associates 15 april 2021.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/458/584/Notification%20and%20publ
ic%20disclosure%20of%20transactions%20by%20Primary%20Insiders%20and%20their%20Cl
ose%20Associates%2015%20april%202021.pdf